<DOC>
	<DOCNO>NCT00676117</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic profile Esomeprazole ( D961H ) repeat oral administration without co-administration loxoprofen pharmacokinetic profile loxoprofen repeat oral administration without co-administration Esomeprazole ( D961H ) .</brief_summary>
	<brief_title>Drug-Drug Interaction Study Esomeprazole ( D961H ) Capsule Loxoprofen Tablet After Repeated Oral Administration Japanese Males</brief_title>
	<detailed_description />
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy Japanese male Body Mass Index ( BMI=weight/height2 ) 1927 ( kg/m2 ) Body weight 5080 kg Past present NSAIDs induce asthma , hepatic dysfunction , peptic ulcer blood disorder Significant clinical illness 2 week precede preentry visit randomisation , judge investigator ( ) , eg , acute inflammatory disease require medical intervention Past present cardiac , renal , hepatic , neurological gastrointestinal disease , judge investigator ( ) , eg , sequelae myocardial infarction , nephritis , hepatitis cerebral infarction</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>male</keyword>
	<keyword>Japan</keyword>
	<keyword>Japanese</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>